Access Hope
1-on-1 support, free of charge,
to find the best treatment for
your advanced cancer
We’re building a Commons so that patients, physicians, and scientists can seamlessly learn and benefit from the latest outcomes of innovative treatments
Advanced cancer is personal, but you don’t have to face it alone. Our experts review your medical records and work with you to find your best treatment options
News & Events
-
Cancer Commons Founder to Speak at PMWC 2021 Virtual Conference
Cancer Commons founder Marty Tenenbaum, PhD, will join other leading innovators and experts next week as a panelist at the 2021 virtual Precision Medicine World Conference (PMWC). This year’s theme is “21st Century Precision Medicine in the Age of COVID-19.” On Monday, Jan 25, at 1pm PST, Marty will engage with other distinguished panelists in an exploration of how to… Read more »
An End-of-Year Message from Our Executive Director
Despite 2020 creating some of the most difficult circumstances of our lifetimes, it was a year of progress for Cancer Commons. Cancer Commons’ Model Validated Cancer Commons helps patients and their physicians collectively explore the latest and best treatment options far more efficiently than they can as individuals, often via a “molecular tumor board” model that precisely matches patients to… Read more »
Cancer Commons Earns Platinum Seal of Transparency from GuideStar
This month, Cancer Commons earned the 2020 Platinum Seal of Transparency from GuideStar, a database that helps the public evaluate the performance of all nonprofits in the U.S. The Platinum Seal of Transparency is the highest level of recognition offered by GuideStar. To reach the Platinum level, Cancer Commons added extensive information to our profile on GuideStar: basic contact and… Read more »
Our network brings together leading cancer experts, including physicians, clinical researchers, and laboratory scientists
-
Now is the time to be very actively involved in your own care.
Tony Blau, MD
University of Washington -
I’d already been leaning heavily towards a decision, and Emma helped me achieve the final decision…But Emma’s more than a scientist. She is a caring person.
Ellen
Breast cancer patient -
I learned more about my trial options from Emma in a week than I did in 3 years of previous care. Every metastatic patient should know about Cancer Commons. And I love how they use the data to speed up the N-of-1 success stories.
Michelle Kendall
Cancer Patient -
You’re not alone. Cancer Commons is a great resource and sounding board to ask questions and get advice and support.
Karen
Advanced breast cancer patient
